Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 8, Pages e23688
Publisher
Public Library of Science (PLoS)
Online
2011-08-30
DOI
10.1371/journal.pone.0023688
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202
- (2011) Grace A. McComsey et al. JOURNAL OF INFECTIOUS DISEASES
- High prevalence of reduced bone mineral density in primary HIV-1-infected men
- (2010) Marlous L Grijsen et al. AIDS
- Tenofovir treatment of primary osteoblasts alters gene expression profiles: Implications for bone mineral density loss
- (2010) Iwen F. Grigsby et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Rethinking Prevention of HIV Type 1 Infection
- (2010) David N. Burns et al. CLINICAL INFECTIOUS DISEASES
- Comparison of Changes in Bone Density and Turnover with Abacavir‐Lamivudine versus Tenofovir‐Emtricitabine in HIV‐Infected Adults: 48‐Week Results from the ASSERT Study
- (2010) Hans‐Jürgen Stellbrink et al. CLINICAL INFECTIOUS DISEASES
- Low Bone Mineral Density with Tenofovir: Does Statistically Significant Mean Clinically Significant?
- (2010) Andrew Carr et al. CLINICAL INFECTIOUS DISEASES
- Bone health in HIV infection
- (2009) E. Pollock et al. BRITISH MEDICAL BULLETIN
- Simplification of Antiretroviral Therapy with Tenofovir‐Emtricitabine or Abacavir‐Lamivudine: A Randomized, 96‐Week Trial
- (2009) Allison Martin et al. CLINICAL INFECTIOUS DISEASES
- HIV and bone mineral density
- (2009) Patrick WG Mallon CURRENT OPINION IN INFECTIOUS DISEASES
- Frequency of osteoporosis in 46 men with methamphetamine abuse hospitalized in a National Hospital
- (2009) Eun Young Kim et al. FORENSIC SCIENCE INTERNATIONAL
- Tenofovir-associated renal and bone toxicity
- (2009) CLN Woodward et al. HIV MEDICINE
- The Pharmacokinetics and Viral Activity of Tenofovir in the Male Genital Tract
- (2009) Manoli Vourvahis et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Loss of Bone Mineral Density After Antiretroviral Therapy Initiation, Independent of Antiretroviral Regimen
- (2009) Todd T Brown et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Bone Pain Due to Fractures Revealing Osteomalacia Related to Tenofovir-Induced Proximal Renal Tubular Dysfunction in a Human Immunodeficiency Virus-Infected Patient
- (2009) Serge Perrot et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- Low Bone Mineral Density, Renal Dysfunction, and Fracture Risk in HIV Infection: A Cross‐Sectional Study
- (2009) Alexandra Calmy et al. JOURNAL OF INFECTIOUS DISEASES
- Evolution and Predictors of Change in Total Bone Mineral Density Over Time in HIV-Infected Men and Women in the Nutrition for Healthy Living Study
- (2008) Denise L Jacobson et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Bone morphogenetic protein-7 reduces toxicity induced by high doses of methamphetamine in rodents
- (2007) J. Chou et al. NEUROSCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started